Clinical Trial Update: A Phase II Study of DMP 115 to Assess Focal Liver Lesions [Phase 2]

View source ↗

Summary

Phase II study of DMP 115 for focal liver lesions has completed. Sponsor: Lantheus Medical Imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• DMP 115

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Liver Disease | Phase 2 | Status: COMPLETED